‘The ultimate validation of a target is a successful clinical trial’: an interview with Maya Ghoussaini
Member Exclusive Spotlight exclusive Interview
Spotlight on drug target validation, Preclinical studies and Phase I, Technologies and methodologies, Expert interviews
Challenges in the design of reliable immuno-oncology mouse models to inform drug development
What structural modifications can be used for BRD4 inhibitors for their use in leukemia therapy?
3-(Benzyloxy)-1-(5-[18F]fluoropentyl)-5-nitro-1H-indazole: A PET radiotracer to measure acetylcholinesterase in brain